SF Bay Area MACS/WIHS Combined Cohort Study

旧金山湾区 MACS/WIHS 联合队列研究

基本信息

项目摘要

Project Summary The MACS and WIHS are major studies of the long-term natural and treated history of HIV infection in the U.S. The San Francisco Clinical Research Site (SF CRS) proposes to make vital contributions to the MACS/WIHS Combined Cohort Study (MWCCS) scientific agenda through the recruitment and retention of a diverse group of women and men whom are representative of the HIV epidemic in our region (i.e., racially and ethnically diverse, sub-optimal engagement in care); continued scientific leadership of MWCCS including strong mentoring of early career investigators who work with MWCCS; and consistent participation in MWCCS studies. To enroll and retain both men and women with and at risk for HIV consistent with MWCCS targets, we will continue a strategy of multisource recruiting that supports enrollment of participants who represent cases and controls in the local community. We will continue to provide MWCCS scientific and structural leadership by unifying the MACS and WIHS in collaboration with the data analysis and coordination center and the MWCCS Executive Committee, leading new MWCCS integrated scientific working groups, and supporting early career investigators through the collaborative engagement of a large core of senior SF CRS investigators (five with K24 awards) who have outstanding mentorship skills, with the goal of developing a new generation of skilled translational scientists. The SF CRS will provide leadership in several domains of vital importance to the MWCCS scientific agenda including HIV pathogenesis, neurocognitive impairment and brain structure/function, genomics, cardiac electrophysiology, pharmacology, informatics, and comorbidities. Specifically, we propose to: 1) contribute to the understanding of the HIV reservoir through deep phenotyping of leukocyte populations in peripheral blood, gut tissue, endocervical and seminal cells; 2) examine the relationship of HIV and gonadal aging on deficits in neurocognitive functioning; 3) pursue novel electrocardiographic studies to evaluate subclinical cardiac and neurocognitive injury in PLWH; 4) leverage linked studies to better understand inter-relationships of multiple morbidities (e.g., cardiac, peripheral vascular, hepatic, renal, pulmonary, neurocognitive, physical function; and 5) lead genomic (e.g., genetic, epigenetic, mitochondrial) discovery efforts on the outcomes evaluated in the MWCCS.
项目概要 MACS 和 WIHS 是对 HIV 感染的长期自然史和治疗史的主要研究。 美国旧金山临床研究中心 (SF CRS) 提议为 MACS/WIHS 联合队列研究 (MWCCS) 科学议程通过招募和保留 代表我们地区艾滋病毒流行的不同女性和男性群体(即种族 以及种族多样化、护理参与度次优); MWCCS 持续的科学领导地位,包括 对参与 MWCCS 的早期职业调查员提供强有力的指导;并持续参与 MWCCS 研究。根据 MWCCS 招募和留住患有艾滋病毒和有感染艾滋病毒风险的男性和女性 目标,我们将继续采取多源招募战略,支持以下参与者的注册 代表当地社区的病例和控制措施。我们将继续为 MWCCS 提供科学和 通过将 MACS 和 WIHS 与数据分析和协作相结合来实现结构领导力 协调中心和 MWCCS 执行委员会,领导新的 MWCCS 综合科学 工作组,并通过大量人员的协作参与来支持早期职业调查人员 SF CRS 高级调查员核心(五名获得 K24 奖项),他们具有出色的指导能力, 培养新一代熟练的转化科学家的目标。 SF CRS 将在以下方面发挥领导作用: 对 MWCCS 科学议程至关重要的几个领域,包括艾滋病毒发病机制、 神经认知障碍和大脑结构/功能、基因组学、心脏电生理学、药理学、 信息学和合并症。具体来说,我们建议:1)促进对艾滋病毒的了解 通过对外周血、肠道组织、宫颈内膜和 精细胞; 2)检查艾滋病毒和性腺衰老与神经认知功能缺陷的关系; 3)开展新的心电图研究,以评估亚临床心脏和神经认知损伤 感染者和艾滋病患者; 4) 利用关联研究更好地了解多种疾病之间的相互关系(例如心脏病、 周围血管、肝、肾、肺、神经认知、身体功能; 5) 主要基因组(例如, 遗传、表观遗传、线粒体)发现工作对 MWCCS 中评估的结果进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bradley E Aouizerat其他文献

1103-194 Identification of novel genetic markers associated with risk of myocardial infarction from a genomic scale scan of putative functional polmorphisms
  • DOI:
    10.1016/s0735-1097(04)92064-5
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Dov Shiffman;May Luke;Olga Iakoubova;Bradley E Aouizerat;Christian A Zellner;Clive R Pullinger;Denis W Drew;Joseph J Catanese;Diane U Leong;Dongming Liu;Judy Z Louie;David Lew;Carmen H Tong;David A Ross;Linda B McAllister;Charles M Rowland;Kit F Lau;James J Devlin;Mary J Malloy;John P Kane
  • 通讯作者:
    John P Kane

Bradley E Aouizerat的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bradley E Aouizerat', 18)}}的其他基金

Proteomic Profiling of Cardiac Dysfunction in the MACS-WIHS Combined Cohort Study
MACS-WIHS 联合队列研究中心脏功能障碍的蛋白质组学分析
  • 批准号:
    10658720
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    10202118
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
Assessing Function and Performance of Population Sexual Orientation and Gender Identity (SOGI) Research Measures in a Racially Diverse HIV-Specific National Cohort
评估不同种族的艾滋病毒特定国家队列中人口性取向和性别认同 (SOGI) 研究措施的功能和表现
  • 批准号:
    10334307
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    9904785
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    10225047
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    10612720
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    10371250
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
SF Bay Area MACS/WIHS Combined Cohort Study
旧金山湾区 MACS/WIHS 联合队列研究
  • 批准号:
    10392771
  • 财政年份:
    2019
  • 资助金额:
    $ 46.28万
  • 项目类别:
Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection
HIV 感染背景下合并药物滥用的神经病 DNA 甲基化生物印记的特征选择
  • 批准号:
    10404953
  • 财政年份:
    2018
  • 资助金额:
    $ 46.28万
  • 项目类别:
Defining the impact of injection drug use on antiretroviral therapy and HIV treatment outcomes: an (epi)genomic approach
定义注射吸毒对抗逆转录病毒治疗和艾滋病毒治疗结果的影响:(表观)基因组方法
  • 批准号:
    9976483
  • 财政年份:
    2018
  • 资助金额:
    $ 46.28万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 46.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了